Table 5.
Predictors of overall survival.
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
| Age (y) | 0.994 | 0.965-1.023 | 0.671 | |||
| Gender | ||||||
| Male | 1 | |||||
| Female | 1.030 | 0.572-1.855 | 0.921 | |||
| Hepatitis types | ||||||
| None | 1 | |||||
| B | 1.670 | 0.858-3.250 | 0.131 | |||
| C | 0.920 | 0.420-2.017 | 0.835 | |||
| AFP level before treatment | 1.000 | 1.000-1.000 | 0.115 | |||
| AFP level after treatment | 1.000 | 1.000-1.000 | 0.108 | |||
| Child-Pugh class | ||||||
| A | 1 | 1 | ||||
| B | 2.064 | 1.184-3.597 | 0.011 | 2.345 | 1.320-4.164 | 0.004 |
| BCLC stage | ||||||
| A | 1 | |||||
| B | 0.726 | 0.426-1.237 | 0.726 | |||
| Number of tumors | ||||||
| 2 | 1 | |||||
| 3 | 0.936 | 0.574-1.526 | 0.790 | |||
| Largest tumor diameter | 1.047 | 0.904-1.212 | 0.539 | |||
| Treatment options | ||||||
| Combined treatment | 1 | 1 | ||||
| TACE only | 1.530 | 0.987-2.370 | 0.057 | 1.692 | 1.081-2.649 | 0.022 |
AFP, alpha-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; TACE, transarterial chemoembolization.